NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DeepSeq.AI, Inc.

DeepSeq.AI, Inc.

Private
Sacramento, CaliforniaHealthcare & Life Scienceshttps://www.deepseq.ai/

Last Round

Seed

Jan 12, 2026

Total Funding Raised

$849,797

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DeepSeq.AI, Inc. is a biotechnology company that develops an AI-driven protein engineering platform to accelerate the discovery and optimization of biologics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

protein drug discoverygenerative AIbiologics designprotein engineeringin silico drug discoverylarge language modelsLLMhigh-throughput screeningprotein-protein interactionPPItherapeutic optimizationAI-driven biotechdrug discovery platformwet-lab automationbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepSeq.AI, Inc. Comparables

Compare DeepSeq.AI, Inc. with similar companies based on industry and business-model similarity.

DeepSeq.AI, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
310.ai
87%
Abiologics
82%
Nabla Bio
80%

DeepSeq.AI, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 12, 2026
GrantMay 21, 2025
GrantAug 19, 2024
GrantJul 15, 2024
AcceleratorNov 1, 2023

DeepSeq.AI, Inc. Investors

Notable investors and investment history

DeepSeq.AI, Inc. investors
InvestorRounds
McKesson VenturesAccelerator
Berkeley SkyDeckAccelerator
Northpond VenturesAccelerator
ZAKA VCSeed
Merck Digital Sciences StudioAccelerator
National Science FoundationGrant
Illumina VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    CEO Andrew Chang to present at SynBioBeta conference on May 5, 2026.

  • Jul 15, 2024

    Secured $275K from the National Science Foundation.

DeepSeq.AI, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepSeq.AI, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepSeq.AI, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSacramento, California
Employee Range6
Year Founded2019
Last FundingJan 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.